Literature DB >> 21425266

Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.

Dean M Wingerchuk1.   

Abstract

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system. Although its cause is not known, genetic and environmental factors both influence susceptibility to the disease. From the large array of environmental risk factors that have been examined over the past century, infection with Epstein-Barr virus, ultraviolet light exposure/vitamin D status, and cigarette smoking stand out because of the strength of supporting evidence. Epstein-Barr virus infection early in life appears to be necessary permissive step for disease development and probably acts in adolescence and early adulthood. Vitamin D-related mechanisms and cigarette smoking probably modify baseline disease risk and could plausibly do so at several stages of life; smoking appears to negatively affect disease course. This review summarizes current evidence for these 3 putative multiple sclerosis risk factors and early attempts to develop risk models and examine gene-environment interactions for this complex disease.
© 2011 Mount Sinai School of Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21425266     DOI: 10.1002/msj.20240

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  14 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  New and emerging immune-targeted drugs for the treatment of multiple sclerosis.

Authors:  Alan M Palmer
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

3.  Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases.

Authors:  A Wiedemann; M Kaeder; W Greulich; H Lax; J Priebel; R Kirschner-Hermanns; I Füsgen
Journal:  World J Urol       Date:  2012-01-07       Impact factor: 4.226

4.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

5.  Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan.

Authors:  Ching-Piao Tsai; Charles Tzu-Chi Lee
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

6.  Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.

Authors:  Mahbubeh Saei; Kourosh Holakouie-Naieni; Ehsan Mostafavi; Mohammad Ali Sahraian; Mahmood Mahmoodi; Mohammad Ali Mansournia; Ali Hosseini
Journal:  Iran J Public Health       Date:  2014-05       Impact factor: 1.429

7.  Progress in multiple sclerosis genetics.

Authors:  An Goris; Ine Pauwels; Bénédicte Dubois
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

8.  Multiple sclerosis and the blood-central nervous system barrier.

Authors:  Alan M Palmer
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-01-15

Review 9.  Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Jilpa Patel; Roumen Balabanov
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

10.  Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.

Authors:  Aref Hosseini; Kamran Ghaedi; Somayeh Tanhaei; Mazdak Ganjalikhani-Hakemi; Shohreh Teimuri; Masoud Etemadifar; Mohammad Hossein Nasr Esfahani
Journal:  Cell J       Date:  2016-08-24       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.